華人健康(301408.SZ)2024年度淨利潤增20.09%至1.38億元 擬10派1元
格隆匯4月24日丨華人健康(301408.SZ)發佈2024年年度報告,2024年度,公司營業收入再創新高,元,比上年同期增長19.34%;歸屬於母公司所有者的淨利潤爲1.38億元,比上年同期增長20.09%;歸屬於母公司所有者的扣除非經常性損益淨利潤1.29億元,比上年同期增長21.81%,其中研發費用爲2,938.73萬元,比上年同期增長21.46%。公司經營性現金流量持續改善,經營質量穩步提升。
報告期內,公司堅持"深耕安徽、聚焦華東、輻射周邊"的發展戰略,保持戰略定力,堅持穩步發展,堅持直營爲主,通過"新開+併購"形式,新增門店440家,其中自建門店70家,併購門店370家,進入浙江舟山、湖州等新市場。截至報告期末,公司門店總數1,774家,較上期末淨增門店391家。同時堅持精細化管理思路,在商品、營運等方面實行精細化管理,以"三降三提升"等管理舉措爲抓手,實現快速發展與規模擴張的同時,注重精細化管理與效益提升的有機融合,取得了顯着的經營成果,併成功樹立了零售品牌的良好口碑。
公司經本次董事會審議通過的利潤分配方案爲:以400,010,000股爲基數,向全體股東每10股派發現金紅利1元(含稅),送紅股0股(含稅),以資本公積金向全體股東每10股轉增0股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.